A portable electronic nose can effectively detect precursors of oesophageal cancer, report researchers from the Radboud university medical center in the medical science journal GUT. This was demonstrated in an initial study involving more than four hundred patients. In time, this inexpensive and non-invasive technique may be used diagnostically to detect the precursor of oesophageal cancer (Barrett’s oesophagus) in general practice.
The number of cases of oesophageal cancer and its precursor - Barrett's oesophagus - has increased enormously in recent decades. The disease is usually diagnosed late and at an advanced stage, which makes treatment difficult. Barrett’s oesophagus is a pre-stage of oesophageal cancer, in which healthy, white-coloured cells at the base of the oesophagus have been replaced by aberrant, pink cells. The diagnosis of Barrett's oesophagus is done by using an endoscope with a camera that enters the oesophagus. An unpleasant and expensive procedure, which is poorly suited for population screening.
Researchers from Radboud university medical center, Bernhoven and CWZ therefore took a closer look at a less expensive and less cumbersome option. They investigated whether good diagnoses are possible with a portable electronic nose. An e-Nose, which measures volatile organic compounds (VOC) in exhaled air. These gaseous compounds are formed during all kinds of metabolic processes in the body. The idea is that changes in metabolism also lead to a different mix of these compounds. In this manner, you could measure inflammation through exhaled air, for instance, but also abnormal activities in the cells, thanks to the characteristic profiles that accompany them. The question is, how well could you smell Barrett’s oesophagus using such an e-Nose?
Of the more than 400 patients who participated in the study, 129 had Barrett's oesophagus and 141 had reflux (gastric acid returning to the oesophagus). 132 patients functioned as controls. Yonne Peters, Gastroenterologist researcher at Radboudumc: "After analysis, we saw markedly different exhalation profiles for these three groups. The sensitivity to detecting Barrett's oesophagus was high, namely 91 percent. This means that the test detects 91 out of 100 people with Barrett's oesophagus based on their exhalation profile. Selection of people who don't have Barrett's oesophagus - the specificity - is 74 percent."
"These figures are comparable to breast and colon cancer screening,” says gastroenterologist and research coordinator Peter Siersema. "After these encouraging results, further research among larger groups of people is obviously needed. If these results persist, its user-friendliness and low cost could contribute to making this breathalyser test interesting for non-invasive screening of Barrett's oesophagus by general practitioners."
Publication in GUT Detection of Barrett’s oesophagus through exhaled breath using an electronic nose device
Yonne Peters, Ruud W M Schrauwen, Adriaan C Tan, Sanne K Bogers, Bart de Jong, Peter D Siersema
Related news items
Dutch-Nordic Alliance for Precision Cancer Medicine launched26 November 2021
The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.read more
Last chance - Call for nominations Supervisor of the Year & Image award25 November 2021
The RIMLS PhD Council has extended the deadline to 1 December to nominate supervisors and images for the supervisor of the year and image awards. Send in your nominations while you still can!read more
The effects of dopamine levels on reward responsivity25 November 2021
To adapt to the ever-changing context in which we live, we are constantly deciding how much effort to put into performing our behavior, or how fast to perform our actions. How do people decide how fast to act and how does the brain compute this? Our researchers set out to investigate this.read more
Academic collaboration agreement between UTwente and Radboudumc23 November 2021
The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc.read more
New anti-inflammatory drugs increase risk of fungal infection22 November 2021
Investigators at the Department of Internal Medicine / Infectious Diseases and Dermatology demonstrate worldwide side effects of certain so-called biologics using four different research approachesread more